Top 4 Stocks About to Reach Their 52-Week High

A 52-week high is a technical indicator used by some of the world's top traders and investors to determine the current and future value of a stock. In this report we reveal today's top 4 stocks about to reach their 52-week highs.

By clicking the link above you will automatically opt-in to receive emails from FinStrategist

AZN
AstraZeneca PLC
NASDAQ
76.92
Open 76.87 Prev Close 76.9
High 77.07 Low 76.61
Volume 0 Volume (Avg) 6,347,684
52 Week High 63.20 52 Week Low 37.12
Market Cap 128.3B PE Ratio 37.67

Shares Stats

Shares Outstanding2,625,440,000
Shares Float2,616,595,074
Shares Short86,279,895
Insider Holdings0%
Institution Holdings16.82%

About AstraZeneca PLC

AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. The company's marketed products include Tagrisso, Lynparza, Imfinzi, Enhertu, Koselugo, Lumoxiti, Equidacent, Zoladex, Faslodex, Iressa, Arimidex, Casodex/Cosudex, and others for oncology diseases; Onglyza, Bydureon, Lokelma, Byetta, Qtern, Symlin, and others for cardiovascular, renal, and metabolism diseases; and Symbicort, Pulmicort, Fasenra, Daliresp/Daxas, Duaklir, Tudorza/Eklira, Bevespi, Breztri, Anifrolumab, and others for respiratory and immunology diseases. It also offers other medicines and COVID-19 products, including Synagis, Fluenz Tetra/FluMist Quadrivalent, Seroquel IR/Seroquel XR, Vimovo, Movantik/Moventig, Nexium, Losec/Prilosec, and COVID-19 Vaccine AstraZeneca. The company serves primary care and specialty care physicians through distributors and local representative offices. It has a collaboration agreement with Daiichi Sankyo to develop and commercialize DS-1062 for the treatment of trophoblast cell-surface antigen 2 (TROP2) tumor; and AliveCor, Inc. to develop non-invasive potassium monitoring solutions. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

General

NameAstraZeneca PLC
TickerAZN
ExchangeNASDAQ
SectorHealthcare
IndustryDrug Manufacturers-General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees76,100

Highlights

Analyst Target63.73
Market Cap128,322,625,536
PE Ratio37.67
PEG Ratio1.26
EBITDA6,764,000,256

Financials

Curr Year EPS Estimate2.55
Profit Margin0.12
Return on Assets0.04
Return on Equity0.21
Revenue26,616,999,936
Earnings Per Share1.22
Revenue Per Share10.14
Gross Profit21,371,000,000
Quarterly Revenue Growth0.11

Valuation

Trailing PE40.50
Forward PE20.04
Price/Sales (Trailing 12 Mt.)4.94
Price/Book (Most Recent Quarter)8.41

Dividend

AstraZeneca PLC pays out a dividend of $2.80 per share, with a dividend yield of 1.87%.

AZN's last dividend payment was made to shareholders on March 29, 2021.

They pay out 69.83% of their earnings out as a dividend.

Recent Dividends

Mar 25, 2024$0.99
Sep 11, 2023$0.47
Mar 27, 2023$0.99
Sep 12, 2022$0.47
Mar 28, 2022$0.99
Sep 13, 2021$0.45
Mar 29, 2021$0.95
Sep 14, 2020$0.45
Most Popular

Dogecoin Rises 4.45% Amidst Anonymous 120 Million DOGE Transfer To Robinhood

A transfer of 120 million Dogecoin (CRYPTO: DOGE) to the trading platform Robinhood has coincided with a 4.45% surge in the price of the meme crypt

Earn Instant Cash Flow (using THIS tactic) - Ad

Can you imagine earning $1,118,721/hr? That's what greedy Wall Street elites have been pocketing for 22 straight years. And now it's available to you.

Is This Nvidia's Secret Weapon? - Ad

You've likely heard about Nvidia's incredible success in AI. But without this startup's technology, Nvidia's groundbreaking AI chips simply wouldn't be possible. It's still flying under the radar. That could change very soon with a major announcement on the horizon.

Trump Meets With DeSantis, Noem Stirs Up Controversy: How Will Republican Vice President Betting Odds Be Impacted?

The relationship between Donald Trump and Ron DeSantis was heated at times during the Republican primary season, before the Florida governor dropped out of the 2024 presidential election and threw his support behind the

Must-See: Elon's New Invention is Absolutely Insane - Ad

When you click here and see what Elon Musk's new invention does... And how it works... You will NOT believe it. You'll tell yourself this is just science fiction. But Elon just tested this in a real human... And the result was mind-blowing.

AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst

Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine, and achieve a high single-digit CAGR from 2024 to 2029.

One Coin to Rule Them All... - Ad

Hardly any investors are talking about this coin but I believe that's about to change with some potentially huge news! Get in on the ground floor while it's rock bottom with this new how-to guide, just $3.

Jim Cramer Advises Investors To Stick With Good Companies Despite Short-Term Losses: 'You Just Need To Figure Out Which Companies Deserve Your Confidence'

Cramer, a prominent figure in the finance world, suggested that investors should not emulate the trading habits of large hedge funds. Instead, he recommended a long-term investment strategy, emphasizing the need to anticipate and endure market declines.

PASSIVE INCOME (by this evening) - Ad

Hey, I have an unique opportunity for those looking for additional ways to earn income right now. It can be done from home. You can do it in your spare time. And it only takes 6 clicks and as little as $50.

Elon Musk Shares Who He'd Want To Spend His Last Moments With In Response To Warren Buffett's Advice

Over the weekend, Elon Musk agreed with a sentiment shared by investment titan Warren Buffett about the importance of spending time with loved ones, despite their contrasting investment philosophies. 

Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition

The Danish pharmaceutical company is now shipping more introductory doses of Wegovy to the U.S., as it grapples with supply constraints and competition from Eli Lilly.

Should You Buy Bitcoin in 2024? [Expert's Shocking Answer] - Ad

Bitcoin minted 100,000 millionaires and if you're not one of them, that ship has sailed. But there's another millionaire-minting crypto at our doorstep... research shows this coin could be 20X bigger than Bitcoin by the end of the decade. With crypto starting to heat up again, this could be the perfect time to get in.

Three groups are suing New Jersey to block an offshore wind farm

LONG BEACH TOWNSHIP, N.J. (AP) — Three anti-wind power groups are suing New Jersey to overturn a key environmental approval for a wind energy farm planned off the coast of Long Beach Island.

AI & Crypto in One $11 Investment - Ad

Right now, you can harness the power of two bull markets... Artificial intelligence and cryptos...In one simple $11 investment.

Fraudsters target small businesses with scams. Here are some to watch out for

NEW YORK (AP) — It's never fun to be scammed, but if you're a small business owner then falling for a scam can have long-lasting effects on a business, damaging client relationships and profit.

America Has New Type of Money, Making Some Rich...Should You Get It? - Ad

One of America's most controversial CEOs says, "A new form of money in America is making some people (including Elon Musk, Jeff Bezos, and 17 of America's 25 wealthiest individuals), rich. It has nothing to do with gold, bitcoin, or anything like that, but it's 100% legal. The problem? Few Americans have a real understanding of how it works.

The SEC charges Trump Media's newly hired auditing firm with 'massive fraud'

SAN FRANCISCO (AP) — The Securities and Exchange Commission on Friday charged an auditing firm hired by Trump Media and Technology Group just 37 days ago with “massive fraud” — though not for any work it performed for former President Donald Trump’s media company.

Stock Market Rally For 2024 Has Peaked, Goldman Sachs Forecasts 'Flat Return From Now Till The End Of The Year'

The stock market rally for 2024 has reached its peak, according to Goldman Sachs. The firm's chief U.S. equity strategist, David Kostin, has predicted a flat return for the S&P 500 for the remainder of the year.

Mysterious Gold Leverage Just Announced - Ad

Ex-Goldman Sachs VP reveals a secret of the rich and connected that lets you tap into the upside of a huge amount of real, physical gold for just a few dollars at a time. He says the upside could be near 1,000% in the coming future.

Poland is still not ready to adopt the euro, its finance minister says

WARSAW, Poland (AP) — Twenty years after joining the European Union, Poland is still not ready to adopt the euro currency, the finance minister in the pro-European Union government said.

Microsoft's Satya Nadella To Employees: 'Prioritize Security Above New Features'

CEO Satya Nadella drives Microsoft's security overhaul in response to recent cyber threats, prioritizing protection post-breaches.

The No. 1 Crypto for 2024 - Ad

It's expected to soar 20X bigger than Bitcoin.

How to design a volunteering program in your workplace

More workplaces are bolstering their volunteer programs, especially as employee demands grow for socially responsible employers and engagement. Nearly three in five companies surveyed by the Association of Corporate Citizenship Professionals reported last year.

South Sudan removes newly imposed taxes that had triggered suspension of UN food airdrops

JUNA, South Sudan (AP) — Following an appeal from the United Nations, removed recently imposed taxes and fees that had triggered suspension of U.N. food airdrops. Thousands of people in the country depend on aid from the outside.

America Just Hit a Grim Milestone - Ad

Nearly half of U.S. households currently hold no retirement savings. Retirement expert Dr. David Eifrig says what happens next will separate a small number of winners from a very large number of losers. Learn how to protect yourself and your money with his four simple steps that he shares right here.

Berkshire Hathaway event gives good view of Warren Buffett's successor but also raises new questions

This year's gave shareholders their best chance yet to hear from the man who will one day take over as CEO when Warren Buffett is gone, but Buffett said for the first time Saturday that should also take responsibility for the company's investments after he takes over, raising new questions about the succession plan.

Crypto Millionaires Names His Favorite AI Coin - Ad

According to Bitcoin pioneer and crypto millionaire Charlie Shrem, a tiny $11 project could be the biggest winner of not just the next year, but the next decade. It combines AI and crypto, in one investment.

Your tax refund could be bigger this year. Here's what to do with it

NEW YORK (AP) — The average taxpayer is getting a $2,852 refund, $75 more than last year, based on the most recent IRS data. So what should you ?

Defi Coin Triggers All "Buy" Signals and Could Break Out Soon - Ad

Some are calling this the most promising DeFi project since Ethereum itself. Here's the #1 DeFi Coin Set to Soar. While Bitcoin grabs headlines, this lesser known DeFi coin is quietly gearing up for a monster rally. Experts say now is the time to buy before it reaches escape velocity.

Alabama Mercedes-Benz Workers Reject UAW Unionization Bid In A Blow To Organized Labor's Southern Strategy

In a blow to organized labor's Southern strategy, Alabama Mercedes-Benz workers rejected unionization, signaling difficulty for UAW's expansion.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service